Off-label use of 4-factor prothrombin complex concentrate is common despite little known benefit: A retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Off-label use of 4-factor prothrombin complex concentrate is common despite little known benefit: A retrospective study

Published:2018-07-27 Issue:3 Volume:101 Page:349-353
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Scharman Carlton D.¹^ORCID,Shatzel Joseph J.²^ORCID,Kim Edward³,DeLoughery Thomas G.²^ORCID

Affiliation:

1. Department of Internal Medicine; Oregon Health & Science University; Portland OR USA

2. Division of Hematology & Medical Oncology; Knight Cancer Institute; Oregon Health & Science University; Portland OR USA

3. School of Medicine; Oregon Health & Science University; Portland OR USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13105/fullpdf

Reference15 articles.

1. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study;Sarode;Circulation,2013

2. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial;Steiner;Lancet Neurol,2016

3. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines;Holbrook;Chest,2012

4. 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American college of cardiology task force on expert consensus decision pathways;Tomaselli;J Am Coll Cardiol,2017

5. Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers;Levi;J Thromb Haemost,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance Review;Thrombosis and Haemostasis;2024-07-29

2. Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-05

3. Ultra-Early Hemostatic Therapy for Acute Intracerebral Hemorrhage: An Updated Review;Cardiology in Review;2024-03-21

4. Utilization and safety of off-label prothrombin complex concentrate (4F-PCC) in a nonsurgical population;Blood Coagulation & Fibrinolysis;2024-02-28

5. Multicenter experience with andexanet alfa for refractory pericardial bleeding during catheter ablation of atrial fibrillation;Journal of Cardiovascular Electrophysiology;2023-01-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3